Is Serum Vasohibin-1 Level Associated with the Development of Kidney Disease in Diabetic Patients?
Yıl: 2023 Cilt: 32 Sayı: 2 Sayfa Aralığı: 112 - 119 Metin Dili: İngilizce DOI: 10.5152/turkjnephrol.2023.2228298 İndeks Tarihi: 02-05-2023
Is Serum Vasohibin-1 Level Associated with the Development of Kidney Disease in Diabetic Patients?
Öz: Objective: Glomerular neoangiogenesis contributes to increased glomerular filtration rate in patients with diabetic kidney disease. Vasohibin-1 is a neoangiogenesis inhibitor. We aimed to evaluate serum vasohibin-1 levels of diabetic patients with and without diabetic kidney disease. Methods: A total of 105 diabetic patients and 35 healthy controls were included in the study. Diabetic patients with estimated glomerular filtration rate <60 mL/min/1.73 m2 and/or those who had persistent proteinuria (>200 mg/g) measured by urinary protein/creatinine ratio were diagnosed as diabetic kidney disease patients if they do not have any other known kidney diseases or findings suggesting another kidney disease. Serum creatinine, estimated glomerular filtration rate, protein/ creatinine ratio, and vasohibin-1 levels were recorded. Results: Systolic blood pressure and protein/creatinine ratio were higher in diabetic patients than in healthy controls, and age, sex, and estimated glomerular filtration rate were similar. Diabetic patients have slightly lower but statistically nonsignificant serum vasohibin-1 levels than healthy controls. Patients with diabetic kidney disease had higher protein/creatinine ratio, lower estimated glomerular filtration rate, and long-standing diabetes compared to diabetic patients without kidney disease. Serum vasohibin-1 levels were similar between patients with and without diabetic kidney disease. There was no correlation between serum vasohibin-1 levels and estimated glomerular filtration rate or protein/creatinine ratio. In logistic regression analysis, vasohibin-1 was not associated with diabetic kidney disease. Conclusion: We showed that diabetic patients have slightly lower vasohibin-1 levels than healthy subjects but there was no difference between diabetic patients with and without kidney disease in terms of serum vasohibin levels. Because vasohibin- 1 exhibits its antiangiogenic properties by acting via autocrine-paracrine pathways, local vasohibin activity at the tissue level may be more important than the circulating levels.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032-2045. [CrossRef]
- 2. Makino H, Kashihara N, Sugiyama H, et al. Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes. Diabetes. 1996;45(4):488-495. [CrossRef]
- 3. Sharma K, Ziyadeh FN. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor- A as a key mediator. Diabetes. 1995;44(10):1139-1146. [CrossRef]
- 4. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988;318(20):1315-1321. [CrossRef]
- 5. Guo M, Ricardo SD, Deane JA, Shi M, Cullen-McEwen L, Bertram JF. A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy. J Anat. 2005;207(6): 813-821. [CrossRef]
- 6. Nyengaard JR, Rasch R. The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia. 1993;36(3):189-194. [CrossRef]
- 7. Veron D, Reidy KJ, Bertuccio C, et al. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease. Kidney Int. 2010;77(11):989-999. [CrossRef]
- 8. Tsuchida K, Makita Z, Yamagishi S, et al. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitör. Diabetologia. 1999;42(5):579-588. [CrossRef]
- 9. Cooper ME, Vranes D, Youssef S, et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes. 1999;48(11):2229- 2239. [CrossRef]
- 10. Watanabe K, Hasegawa Y, Yamashita H, et al. Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis. J Clin Invest. 2004;114(7):898-907. [CrossRef]
- 11. Sato Y. The vasohibin family: A novel family for angiogenesis regulation. J Biochem. 2013;153(1):5-11. [CrossRef]
- 12. Nasu T, Maeshima Y, Kinomura M, et al. Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy. Diabetes. 2009;58(10): 2365-2375. [CrossRef]
- 13. Saito D, Maeshima Y, Nasu T, et al. Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis. Am J Physiol Ren Physiol. 2011;300:873-886.
- 14. Ren H, Shao Y, Wu C, Lv C, Zhou Y, Wang Q. VASH-1 regulates oxidative stress and fibrosis in diabetic kidney disease via SIRT1/HIF1α and TGFβ1/Smad3 signaling pathways. Front Mol Biosci. 2020;7:137. [CrossRef]
- 15. Mottl AK, Tuttle KR, Bakris GL. Diabetic kidney disease: manifestations, evaluation, and diagnosis. In: Post TW, ed. UpToDate. UpTo- Date, Waltham, MA; 2021. Accessed on November 27, 2021.
- 16. McGrath K, Edi R. Diabetic kidney disease: diagnosis, treatment, and prevention. Am Fam Phys. 2019;99(12):751-759.
- 17. Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032-2045. [CrossRef]
- 18. Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (chronic kidney disease epidemiology collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;5(150):604-612.
- 19. Osterby R, Nyberg G. New vessel formation in the renal corpuscles in advanced diabetic glomerulopathy. J Diabet Complications. 1987;1(4):122-127. [CrossRef]
- 20. Kanesaki Y, Suzuki D, Uehara G, et al. Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy. Am J Kidney Dis. 2005;45(2): 288-294. [CrossRef]
- 21. Hohenstein B, Hausknecht B, Boehmer K, Riess R, Brekken RA, Hugo CPM. Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int. 2006; 69(9):1654-1661. [CrossRef]
- 22. Maeshima Y, Makino H. Angiogenesis and chronic kidney disease. Fibrogenesis Tissue Repair. 2010;5;3:13. [CrossRef]
- 23. Hovind P, Tarnow L, Oestergaard PB, Parving HH. Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy. Kidney Int. 2000;57:56-61.
- 24. Kim NH, Oh JH, Seo JA, et al. Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in dibetic nephropathy. Kidney Int. 2005;67(1):167-177. [CrossRef]
- 25. Bates DO, Curry FE. Vascular endothelial growth factor increases microvascular permeability via a Ca2+-dependent pathway. Am J Physiol. 1997;273(2):87-694.
- 26. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marmé D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood. 1996;87(8):3336-3343. [CrossRef]
- 27. Hinamoto N, Maeshima Y, Yamasaki H, et al. Exacerbation of diabetic renal alterations in mice lacking vasohibin-1. PLoS One. 2014;25(9):107934.
- 28. Ren H, Shao Y, Ma X, Yang M, Liu Y, Wang Q. Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios. J Diabetes Complications. 2019;33(7):477-484. [CrossRef]
- 29. Hinamoto N, Maeshima Y, Saito D, et al. Urinary and plasma levels of Vasohibin-1 can predict renal functional deterioration in patients with renal disorders. PLoS One. 2014;9(6):e96932. [CrossRef]
- 30. Tanimura S, Tanabe K, Miyake H, et al. Renal tubular injury exacerbated by Vasohibin-1 deficiency in a murine cisplatin-induced acute kidney injury model. Am J Physiol Ren Physiol. 2019;317(2):F26 4-F274. [CrossRef]
- 31. Hinamoto N, Maeshima Y, Saito D, et al. Renal distribution of Vasohibin- 1 in patients with chronic kidney disease. Acta Med Okayama. 2014;68(4):219-233. [CrossRef]
- 32. Fisher H, Hsu CY, Vittinghoff E, Lin F, Bansal N. Comparison of associations of urine protein-creatinine ratio versus albumin-creatinine ratio With complications of CKD: a cross-sectional analysis. Am J Kidney Dis. 2013;62(6):1102-1108. [CrossRef]
- 33. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis. 2002;39:1-11.
| APA | Tütüncü D, seyithanoğlu m, sahin m, öztürk i, Duygu F, Eren N, Gungor O, Altunoren O (2023). Is Serum Vasohibin-1 Level Associated with the Development of Kidney Disease in Diabetic Patients?. , 112 - 119. 10.5152/turkjnephrol.2023.2228298 |
| Chicago | Tütüncü Didem,seyithanoğlu muhammed,sahin murat,öztürk ilyas,Duygu Fatma betül,Eren Necmi,Gungor Ozkan,Altunoren Orcun Is Serum Vasohibin-1 Level Associated with the Development of Kidney Disease in Diabetic Patients?. (2023): 112 - 119. 10.5152/turkjnephrol.2023.2228298 |
| MLA | Tütüncü Didem,seyithanoğlu muhammed,sahin murat,öztürk ilyas,Duygu Fatma betül,Eren Necmi,Gungor Ozkan,Altunoren Orcun Is Serum Vasohibin-1 Level Associated with the Development of Kidney Disease in Diabetic Patients?. , 2023, ss.112 - 119. 10.5152/turkjnephrol.2023.2228298 |
| AMA | Tütüncü D,seyithanoğlu m,sahin m,öztürk i,Duygu F,Eren N,Gungor O,Altunoren O Is Serum Vasohibin-1 Level Associated with the Development of Kidney Disease in Diabetic Patients?. . 2023; 112 - 119. 10.5152/turkjnephrol.2023.2228298 |
| Vancouver | Tütüncü D,seyithanoğlu m,sahin m,öztürk i,Duygu F,Eren N,Gungor O,Altunoren O Is Serum Vasohibin-1 Level Associated with the Development of Kidney Disease in Diabetic Patients?. . 2023; 112 - 119. 10.5152/turkjnephrol.2023.2228298 |
| IEEE | Tütüncü D,seyithanoğlu m,sahin m,öztürk i,Duygu F,Eren N,Gungor O,Altunoren O "Is Serum Vasohibin-1 Level Associated with the Development of Kidney Disease in Diabetic Patients?." , ss.112 - 119, 2023. 10.5152/turkjnephrol.2023.2228298 |
| ISNAD | Tütüncü, Didem vd. "Is Serum Vasohibin-1 Level Associated with the Development of Kidney Disease in Diabetic Patients?". (2023), 112-119. https://doi.org/10.5152/turkjnephrol.2023.2228298 |
| APA | Tütüncü D, seyithanoğlu m, sahin m, öztürk i, Duygu F, Eren N, Gungor O, Altunoren O (2023). Is Serum Vasohibin-1 Level Associated with the Development of Kidney Disease in Diabetic Patients?. Turkish journal of nephrology (Online), 32(2), 112 - 119. 10.5152/turkjnephrol.2023.2228298 |
| Chicago | Tütüncü Didem,seyithanoğlu muhammed,sahin murat,öztürk ilyas,Duygu Fatma betül,Eren Necmi,Gungor Ozkan,Altunoren Orcun Is Serum Vasohibin-1 Level Associated with the Development of Kidney Disease in Diabetic Patients?. Turkish journal of nephrology (Online) 32, no.2 (2023): 112 - 119. 10.5152/turkjnephrol.2023.2228298 |
| MLA | Tütüncü Didem,seyithanoğlu muhammed,sahin murat,öztürk ilyas,Duygu Fatma betül,Eren Necmi,Gungor Ozkan,Altunoren Orcun Is Serum Vasohibin-1 Level Associated with the Development of Kidney Disease in Diabetic Patients?. Turkish journal of nephrology (Online), vol.32, no.2, 2023, ss.112 - 119. 10.5152/turkjnephrol.2023.2228298 |
| AMA | Tütüncü D,seyithanoğlu m,sahin m,öztürk i,Duygu F,Eren N,Gungor O,Altunoren O Is Serum Vasohibin-1 Level Associated with the Development of Kidney Disease in Diabetic Patients?. Turkish journal of nephrology (Online). 2023; 32(2): 112 - 119. 10.5152/turkjnephrol.2023.2228298 |
| Vancouver | Tütüncü D,seyithanoğlu m,sahin m,öztürk i,Duygu F,Eren N,Gungor O,Altunoren O Is Serum Vasohibin-1 Level Associated with the Development of Kidney Disease in Diabetic Patients?. Turkish journal of nephrology (Online). 2023; 32(2): 112 - 119. 10.5152/turkjnephrol.2023.2228298 |
| IEEE | Tütüncü D,seyithanoğlu m,sahin m,öztürk i,Duygu F,Eren N,Gungor O,Altunoren O "Is Serum Vasohibin-1 Level Associated with the Development of Kidney Disease in Diabetic Patients?." Turkish journal of nephrology (Online), 32, ss.112 - 119, 2023. 10.5152/turkjnephrol.2023.2228298 |
| ISNAD | Tütüncü, Didem vd. "Is Serum Vasohibin-1 Level Associated with the Development of Kidney Disease in Diabetic Patients?". Turkish journal of nephrology (Online) 32/2 (2023), 112-119. https://doi.org/10.5152/turkjnephrol.2023.2228298 |
